Time to Apply for This Year’s Idea Competition – Flemingsberg Science Award Idea!

Maybe you’ve been carrying an idea for a long time—a spark you believe could create something new, clever, and beneficial for society. Now it’s time to give your dream a chance to become reality.

The Flemingsberg Science Award Idea is a sub-competition within Venture Cup’s national business plan competition, aimed at entrepreneurs, innovators, and anyone eager to develop their ideas. As a participant, you have the chance to win 5,000 SEK in prize money, and one month of free membership in an inspiring coworking environment. To enter, you need to live, study, or work in Flemingsberg.

Don’t wait – seize the opportunity to bring your idea to life and help shape the future.

Deadline: November 9
For guaranteed feedback, submit by: October 23

Apply and read more about the competition here >

Go straight to the Venture Cup application >

Campus Flemingsberg – A Knowledge Hub Shaping the Future Society

At Campus Flemingsberg, nearly 20,000 students study a wide range of subjects, from medical technology and healthcare, to humanities, police training, and music education. It is a place full of knowledge where the foundations of the future society are being laid, and after a pause of three years, the campus day is finally back. It's a day when students and professionals gather at Campus Flemingsberg to kick off the autumn semester together.

Meet Josefine Bresmar: Flemingsberg Science’s new Director of Communications

At the end of the summer, Josefine Bresmar started as Flemingsberg Science’s new Director of Communications. One of Josefine’s main tasks will be to develop the Flemingsberg Business Community network.

Sprint Bioscience in billion-kronor deal to develop new cancer drug

Sprint Bioscience has licensed its VADA cancer programme to US-based Day One Biopharmaceuticals. The deal is Sprint Bioscience’s largest to date and could be worth around SEK 3.4 billion. In the next two years, the two companies will take the steps towards clinical testing of a new cancer drug.

Previous 373839 Next